Outcome of Board Meeting for Approval of Un-Audited Financial Results for the quarter ended on June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Trident Texofab Ltd met and approved the un-audited financial results for the quarter ended June 30, 2025, which is the first quarter of FY2025-26. The announcement is a routine regulatory compliance filing under SEBI's Listing Obligations, confirming the board has reviewed and approved the quarterly results. No specific financial figures, comparisons, or auditor observations are included in this outcome announcement itself. Investors should refer to the detailed financial results filed separately for actual numbers, revenue, profit, and margin data.
This is a procedural filing with no direct impact on the stock price. Shareholders should review the accompanying financial results document to assess the company's Q1 FY26 performance before drawing conclusions.